Arthur Tzianabos's Net Worth
$4.3 Million
Who is Arthur Tzianabos?
Arthur Tzianabos has an estimated net worth of $4.3 Million. This is based on reported shares across multiple companies, which include BIND Therapeutics, Inc, Stoke Therapeutics, Inc., OvaScience, Inc., Akouos, Inc., and Q32 Bio Inc..
SEC CIK
Arthur Tzianabos's CIK is 0001586226
Past Insider Trading and Trends
2024 was Arthur Tzianabos's most active year for acquiring shares with 6 total transactions. Arthur Tzianabos's most active month to acquire stocks was the month of May. 2019 was Arthur Tzianabos's most active year for disposing of shares, totalling 8 transactions. Arthur Tzianabos's most active month to dispose stocks was the month of December. 2024 saw Arthur Tzianabos paying a total of $69,508.41 for 86,660 shares, this is the most they've acquired in one year. In 2021 Arthur Tzianabos cashed out on 20,000 shares for a total of $606,652.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15K |
$0.44 | $6,600.00 | 15K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
∞
| 31.74K |
$2.19 | $69,508.41 | 31.74K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
$31.43 | -$584,752.00 |
0
|
Scheduled
|
Feb 19
| ||
Form 4
|
—
|
0
|
$24.11 | -$876,765.67 |
0
|
Scheduled
|
Nov 23
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OvaScience, Inc. (TPST) Snapshot price: $1.25
President and CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +6,250.00% | 25K |
—
|
—
| 25.4K |
Dec 3
| |||
Form 4
| +128.57% | 225 |
$28.77 | $6,473.25 | 400 |
Apr 9
| |||
Form 4
|
∞
| 175 |
$28.04 | $4,907.00 | 175 |
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
∞
| 1K |
$10.32 | $10,320.00 | 1K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Akouos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.93K |
—
|
—
|
0
|
Nov 30 - Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Q32 Bio Inc. (QTTB) Snapshot price: $45.48
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.60% | 830 |
$24.20 | -$6,413.00 | 7.98K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +18.80% | 20.38K |
$0.57 | -$7,445.43 | 128.78K |
Jan 1 - Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| -8.92% | -10.62K |
$1.39 | -$14,761.55 | 108.39K |
Scheduled
|
Jan 9
| ||
Form 4
| +38.37% | 33K |
—
|
—
| 119.01K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +10.97% | 8.51K |
$3.78 | -$20,239.19 | 86.01K |
Scheduled
|
Jan 1 - Jan 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
| -13.89% | -12.50K |
$16.16 | -$202,021.25 | 77.5K |
Scheduled
|
Feb 3
| ||
Form 4
| -12.19% | -12.50K |
$20.50 | -$256,191.25 | 90K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
| -19.61% | -25.00K |
$16.15 | -$403,735.00 | 102.5K |
Scheduled
|
Nov 29 - Dec 2
| ||
Form 4
| -8.93% | -12.50K |
$17.40 | -$217,467.68 | 127.5K |
Scheduled
|
Oct 1
| ||
Form 4
| -8.20% | -12.50K |
$18.75 | -$234,320.00 | 140K |
Scheduled
|
Sep 3
| ||
Form 4
| -7.58% | -12.50K |
$17.37 | -$217,111.25 | 152.5K |
Scheduled
|
Aug 1
| ||
Form 4
| -7.04% | -12.50K |
$18.98 | -$237,300.00 | 165K |
Scheduled
|
Jul 1
| ||
Form 4
| -6.58% | -12.50K |
$19.86 | -$248,262.50 | 177.5K |
Scheduled
|
Jun 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |